PIPF 031: A Treatment Protocol to Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Trial ID or NCT#
NCT02141087
Status
NOT RECRUITING
Purpose
This is an open label multi-center program to allow patients in the US with IPF access to treatment with pirfenidone.
View on ClinicalTrials.gov